Results 1 to 10 of about 108,951 (180)

Features of the reaction of the cardiovascular system to physical exercise in patients with pulmonary tuberculosis [PDF]

Pedagogìka, Psihologìâ ta Mediko-bìologìčnì Problemi Fìzičnogo Vihovannâ ì Sportu, 2013
The aim is to study the response of the cardiovascular system to physical exercise in patients with infiltrative pulmonary tuberculosis. The features of adaptive capacity of the cardiovascular system was considered to physical stress on the results of ...
Kalmykov S.A., Kalmykova Yu.S.
doaj   +4 more sources

Lipid Levels and Atherogenic Indices as Important Predictive Parameters in the Assessment of Cardiovascular Risk in Patients with Pulmonary Tuberculosis—Slovak Pilot Study [PDF]

Medicina
Background and Objective: Tuberculosis is one of the globally prevalent infectious diseases. Lipids play a crucial role in its development as well as in other diseases of the cardiovascular system.
Karolína Kubalová, Igor Porvazník, Mária Majherová, Lenka Demková, Anna Piotrowska, Marta Mydlárová Blaščáková   +5 more
doaj   +2 more sources

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment.

PLoS ONE, 2023
BackgroundHyperuricemia is common during tuberculosis (TB) treatment, especially in association with pyrazinamide (PZA). This study investigated the relationship between major adverse cardiovascular events (MACEs) and hyperuricemia during TB treatment ...
Hong-Joon Shin, Joon-Young Yoon, Young-Ok Na, Jae-Kyeong Lee, Bo Gun Kho, Tae-Ok Kim, Yu-Il Kim, Sung-Chul Lim, Sae-Hee Jeong, Yong-Soo Kwon   +9 more
doaj   +5 more sources

Exploring the link between cardiovascular risk factors and manifestations in latent tuberculosis infection: a comprehensive literature review

The Egyptian Heart Journal, 2023
Background The global burden of tuberculosis (TB) and cardiovascular disease (CVD) is overt, and the prevalence of this double burden disease remains steadily rising, particularly in low- and middle-income countries.
Irawaty Djaharuddin, Muzakkir Amir, Andriany Qanitha   +2 more
doaj   +3 more sources

Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials [PDF]

Frontiers in Antibiotics
Tuberculosis drug trials are primarily designed to identify antibiotic regimens with the strongest potency to kill Mycobacterium tuberculosis. However, microbiologic cure is not synonymous with improved health and recovery. Beyond antimicrobial efficacy,
Andrew R. DiNardo, Andrew R. DiNardo, Wilbert Sabiiti, Stephen H. Gillespie, Sophia B. Georghiou, Norbert Heinrich, Norbert Heinrich, Norbert Hittel, Sami Taghlabi, Danna Carrero Longlax, Mikashmi Kohli, Ursula Panzner, Ursula Panzner, Collins Musia, Christoph Lange, Christoph Lange, Christoph Lange, Christoph Lange, Anca Vasiliu, Anca Vasiliu, Anca Vasiliu, Rob J. W. Arts, Anna M. Mandalakas, Anna M. Mandalakas, Anna M. Mandalakas, Morten Ruhwald, Lieven J. Stuyver, Reinout van Crevel, Reinout van Crevel   +28 more
doaj   +2 more sources

Association of prior tuberculosis with cardiovascular status in perinatally HIV-1-infected adolescents. [PDF]

Open Heart
BackgroundWhether, and how, co-occurring HIV-1 infection (HIV) and tuberculosis (TB) impact cardiovascular status, especially in adolescents with perinatally acquired HIV (APHIV), have not been examined. We hypothesised that APHIV with previous TB disease have worse cardiac efficiency than APHIV without TB, which is mediated by increased inflammation ...
Magodoro IM, Guerrero-Chalela CE, Carkeek E, Asafu-Agyei NA, Jele N, Frigati LJ, Myer L, Jao J, Ntsekhe M, Wilkinson KA, Wilkinson RJ, Zar H, Ntusi N.   +12 more
europepmc   +4 more sources

Cardiovascular Involvement in Tuberculosis Patients Treated in Southern Africa

JACC: Advances
Background: Tuberculosis (TB) is the leading cause of death among people with HIV and a major global health challenge. Subclinical cardiovascular manifestations of TB are poorly documented in high TB and HIV burden countries.
Daryoush Samim, MD, Guy Muula, MD, MPH, Nicolas Banholzer, PhD, Douglas Chibomba, MD, Sihle Xulu, BSc, Carolyn Bolton, MBBCh, MSc, Denise Evans, PhD, Lisa Perrig, MD, Stefano De Marchi, MD, Gunar Günther, MD, Matthias Egger, MD, MSc, Thomas Pilgrim, MD, MSc, Lukas Fenner, MD, MSc   +12 more
doaj   +2 more sources

Tuberculosis and the Heart

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Acquired tuberculosis continues to be a challenge worldwide. Although tuberculosis has been considered a global public health emergency, it remains poorly controlled in many countries.
José Patricio López‐López, Edith L. Posada‐Martínez, Clara Saldarriaga, Fernando Wyss, Carlos I. Ponte‐Negretti, Bryce Alexander, Andrés Felipe Miranda‐Arboleda, Manuel Martínez‐Sellés, Adrian Baranchuk   +8 more
doaj   +1 more source

Tuberculosis and Cardiovascular Complications: An Overview

Cureus, 2022
Tuberculosis (TB) is a dominant cause of mortality from a single infectious disease agent. It is a global health issue that has been tagged as a public health emergency for decades. The disease process, which is caused by Mycobacterium tuberculosis (MTB), affects the respiratory system as well as many other organ systems in the body, such as the ...
Adefuye, Mayowa A, Manjunatha, Nisha, Ganduri, Vinutna, Rajasekaran, Kruthiga, Duraiyarasan, Shrimahitha, Adefuye, Bolanle O   +5 more
openaire   +2 more sources

Cardiovascular pathology in patients with newly diagnosed tuberculosis and chronic obstructive pulmonary disease

Медицинский совет, 2021
Introduction. Chronic obstructive pulmonary disease and cardiovascular diseases (arterial hypertension, ischemic heart disease, chronic heart failure) are among the comorbid conditions that mutually aggravate each other.
N. V. Bagisheva, A. V. Mordyk, I. A. Viktorova, D. I. Trukhan   +3 more
doaj   +1 more source